After @ weeks , mean HbA@c was @ % ( @ mmol/mol ) for both groups , with IDegAsp achieving the prespecified noninferiority margin for mean change in HbA@c ( estimated treatment difference -LSB- ETD -RSB- -@ % points -LSB- @ % CI -@ to @ -RSB- ) .